Ocular Hemorrhage Possibly the Result of HMG-CoA Reductase Inhibitors

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 2, 2004, Pages 179-182

  Fraunfelder, F W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATINE; WARFARIN;

ADULT; ARTICLE; BLEEDING TIME; CONJUNCTIVAL HEMORRHAGE; DISEASE CLASSIFICATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPHEMA; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; RETINA HEMORRHAGE; RETROSPECTIVE STUDY; VITREOUS HEMORRHAGE; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; EYE HEMORRHAGE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED;

EID: 1842527007     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076804773710858     Document Type: Article

References (6)

1. Hardman, J.G., Limbird, L., and Gilman, A.G. The Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill, 2001.
2. Physicians' Desk Reference. Vol. 56. 2002, Montvale, NJ: Medical Economics. 3355 pages.
3. Bradford, R.H., et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) Study Results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch. Intern. Med. 151:43-49, 1991.
4. Fraunfelder, F.T., and Fraunfelder, F.W. Drug-Induced Ocular Side Effects, 5th ed. Woburn, MA: Butterworth-Heinemann, 2001:824.
5. Edwards, R., and Biriell, C. Harmonisation in pharmacovigilance. Drug Safety 10:93-102, 1994.
6. Hussein, O., et al. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br. J. Clin. Pharmacol. 44:77-84, 1997.